PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 344 filers reported holding PHARMACYCLICS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $125,732,000 | +194.6% | 491,234 | +40.7% | 0.04% | +215.4% |
| Q4 2014 | $42,680,000 | -33.3% | 349,099 | -35.9% | 0.01% | -35.0% |
| Q3 2014 | $63,956,000 | -7.6% | 544,631 | -29.4% | 0.02% | -9.1% |
| Q2 2014 | $69,216,000 | -48.4% | 771,555 | -42.4% | 0.02% | -50.0% |
| Q1 2014 | $134,268,000 | +21.6% | 1,339,738 | +28.3% | 0.04% | +22.2% |
| Q4 2013 | $110,462,000 | +39.2% | 1,044,262 | +82.0% | 0.04% | +24.1% |
| Q3 2013 | $79,339,000 | +8.0% | 573,839 | -37.9% | 0.03% | +3.6% |
| Q2 2013 | $73,429,000 | +138.7% | 923,971 | +73.6% | 0.03% | +115.4% |
| Q4 2012 | $30,756,000 | +86.3% | 532,305 | +108.0% | 0.01% | +85.7% |
| Q3 2012 | $16,505,000 | +62.1% | 255,881 | +37.3% | 0.01% | +75.0% |
| Q2 2012 | $10,179,000 | +965.9% | 186,404 | +442.0% | 0.00% | – |
| Q1 2012 | $955,000 | – | 34,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,010,211 | $1,245,752,000 | 17.70% |
| DAFNA Capital Management LLC | 102,128 | $14,120,000 | 15.42% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 183,390 | $25,355,000 | 4.11% |
| QVT Financial LP | 344,321 | $47,606,000 | 3.24% |
| BB BIOTECH AG | 399,030 | $55,170,000 | 3.00% |
| LMR Master Fund Ltd | 87,269 | $12,079,000 | 2.31% |
| Ithaka Group | 65,420 | $9,045,000 | 2.10% |
| Geduld E E | 22,000 | $3,042,000 | 1.86% |
| Benchmark Capital Advisors | 17,250 | $2,385,000 | 1.71% |
| HealthCor Management, L.P. | 200,000 | $27,652,000 | 1.48% |